• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
PROSTATE-SPECIFIC ANTIGEN (PSA) VALUES IN PATIENTS WITH LOW- AND HIGH-RISK PROSTATIC ADENOCARCINOMA.低风险和高风险前列腺腺癌患者的前列腺特异性抗原（PSA）值
Acta Clin Croat. 2019 Nov;58(Suppl 2):12-15. doi: 10.20471/acc.2019.58.s2.02.
2
Single small focus of prostate adenocarcinoma (< or = 1 mm and too small for grading) and clinical significant disease after radical prostatectomy.前列腺腺癌的单个小病灶（≤1毫米且太小无法分级）以及根治性前列腺切除术后的临床显著疾病。
Arch Ital Urol Androl. 2006 Jun;78(2):57-60.
3
Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.耻骨后根治性前列腺切除术后早期前列腺特异性抗原复发：基于术前和术后肿瘤特征的预测
Eur Urol. 1999;36(1):21-30. doi: 10.1159/000019922.
4
Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: correlation with findings at radical prostatectomy and prognosis.前列腺腺癌，核心穿刺活检 Gleason 评分 9-10：与根治性前列腺切除术的相关性及预后。
J Urol. 2013 Dec;190(6):2068-73. doi: 10.1016/j.juro.2013.05.056. Epub 2013 May 30.
5
The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.前列腺穿刺活检标本中癌阳性核心的百分比强烈预测根治性前列腺切除术中的肿瘤分期和体积。
J Urol. 2000 Jan;163(1):174-8.
6
The results of radical prostatectomy at a community hospital during the prostate specific antigen era.前列腺特异性抗原时代一家社区医院根治性前列腺切除术的结果
Cancer. 1996 Mar 1;77(5):928-33. doi: 10.1002/(sici)1097-0142(19960301)77:5<928::aid-cncr19>3.0.co;2-5.
7
Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma.微血管密度在预测病理分期为T3期前列腺腺癌复发中的作用。
Urology. 1999 Sep;54(3):479-85. doi: 10.1016/s0090-4295(99)00202-2.
8
Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma.三级Gleason评分5是Gleason评分7的前列腺腺癌患者生化复发的有力预测指标。
J Urol. 2006 May;175(5):1695-9; discussion 1699. doi: 10.1016/S0022-5347(05)00998-5.
9
Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.机器人辅助根治性前列腺切除术后患者前列腺特异性抗原持续升高的预测因素及肿瘤学结局
J Robot Surg. 2017 Mar;11(1):37-45. doi: 10.1007/s11701-016-0606-8. Epub 2016 May 31.
10
Gleason score as predictor of clinicopathologic findings and biochemical (PSA) progression following radical prostatectomy.Gleason评分作为根治性前列腺切除术后临床病理结果及生化（前列腺特异抗原）进展的预测指标
Int Braz J Urol. 2008 Jan-Feb;34(1):23-9. doi: 10.1590/s1677-55382008000100005.

本文引用的文献

1
Active treatment in low-risk prostate cancer: a population-based study.低危前列腺癌的积极治疗：一项基于人群的研究。
Curr Oncol. 2019 Aug;26(4):e535-e540. doi: 10.3747/co.26.4953. Epub 2019 Aug 1.
2
Radical prostatectomy for high-risk prostate cancer | Opinion: NO.高危前列腺癌的根治性前列腺切除术 | 观点：否
Int Braz J Urol. 2019 May-Jun;45(3):428-434. doi: 10.1590/S1677-5538.IBJU.2019.03.03.
3
Defining "High Risk" for Men with Localized Prostate Cancer: How Close Can Clinical Parameters Get Us?
Eur Urol Oncol. 2018 Jun;1(2):149-150. doi: 10.1016/j.euo.2018.04.009. Epub 2018 May 15.
4
Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy.高危前列腺癌定义的异质性及其对根治性前列腺切除术后死亡率的不同影响。
Eur Urol Oncol. 2018 Jun;1(2):143-148. doi: 10.1016/j.euo.2018.02.004. Epub 2018 May 15.
5
The percentage of high-grade prostatic adenocarcinoma in prostate biopsies significantly improves on Grade Groups in the prediction of prostate cancer death.前列腺活检中高级别前列腺腺癌的比例在预测前列腺癌死亡方面明显优于分级分组。
Histopathology. 2019 Oct;75(4):589-597. doi: 10.1111/his.13888. Epub 2019 Aug 13.
6
Incidence of metastasis and prostate-specific antigen levels at diagnosis in Gleason 3+4 versus 4+3 prostate cancer.Gleason 3+4与4+3前列腺癌诊断时的转移发生率及前列腺特异性抗原水平
Urol Ann. 2018 Apr-Jun;10(2):203-208. doi: 10.4103/UA.UA_124_17.
7
Approach to the Patient with High-Risk Prostate Cancer.高危前列腺癌患者的诊疗方法
Urol Clin North Am. 2017 Nov;44(4):635-645. doi: 10.1016/j.ucl.2017.07.009.
8
Prognostic parameter for high risk prostate cancer patients at initial presentation.初诊时高危前列腺癌患者的预后参数。
Prostate. 2018 Jan;78(1):11-16. doi: 10.1002/pros.23438. Epub 2017 Nov 2.
9
Unification of favourable intermediate-, unfavourable intermediate-, and very high-risk stratification criteria for prostate cancer.前列腺癌有利的中间风险、不利的中间风险和极高风险分层标准的统一。
BJU Int. 2017 Nov;120(5B):E87-E95. doi: 10.1111/bju.13903. Epub 2017 Jun 3.
10
Association of serum prostate-specific antigen levels with the results of the prostate needle biopsy.血清前列腺特异性抗原水平与前列腺穿刺活检结果的相关性
Bull Cancer. 2016 Sep;103(9):730-4. doi: 10.1016/j.bulcan.2016.05.006. Epub 2016 Jun 23.

低风险和高风险前列腺腺癌患者的前列腺特异性抗原（PSA）值

PROSTATE-SPECIFIC ANTIGEN (PSA) VALUES IN PATIENTS WITH LOW- AND HIGH-RISK PROSTATIC ADENOCARCINOMA.

作者信息

Mašić Silvija, Pezelj Ivan, Krušlin Božo

机构信息

1Ljudevit Jurak Department of Pathology and Cytology, Sestre milosrdnice University Hospital Centre, Zagreb, Croatia; 2Department of Urology, Sestre milosrdnice University Hospital Centre, Zagreb, Croatia; 3Department of Pathology, School of Medicine, University of Zagreb, Zagreb, Croatia.

出版信息

Acta Clin Croat. 2019 Nov;58(Suppl 2):12-15. doi: 10.20471/acc.2019.58.s2.02.

DOI:10.20471/acc.2019.58.s2.02
PMID:34975192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8693563/
Abstract

Prostatic adenocarcinoma (PC) comprises around 19% of malignancies in Croatian male population. On the basis of PSA value, Gleason score, grading group and clinical stage, PC can be classified into low- and high-risk groups which is significant for different therapeutic regimens and prognostic outcomes. In this retrospective study, we analyzed the difference in preoperative PSA value in a group of 272 patients who underwent radical prostatectomy and were diagnosed with PC adenocarcinoma in our institution in a period from January 1, 2018 untill December 31, 2018. Subsequently, they were divided into low- and high-risk prostatic adenocarcinoma groups. Our results demonstrated positive correlation in preoperative PSA values between the groups and therefore support the use of PSA as one of the parameters in defining low- and high-risk prostatic adenocarcinoma categories.

摘要

前列腺腺癌（PC）约占克罗地亚男性人群恶性肿瘤的19%。根据前列腺特异性抗原（PSA）值、 Gleason评分、分级组和临床分期，PC可分为低风险和高风险组，这对于不同的治疗方案和预后结果具有重要意义。在这项回顾性研究中，我们分析了2018年1月1日至2018年12月31日期间在我们机构接受根治性前列腺切除术并被诊断为PC腺癌的272例患者术前PSA值的差异。随后，他们被分为低风险和高风险前列腺腺癌组。我们的结果表明，两组之间术前PSA值呈正相关，因此支持将PSA用作定义低风险和高风险前列腺腺癌类别的参数之一。